FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2053662475> ?p ?o ?g. }

• W2053662475 endingPage "e79775" @default.
• W2053662475 startingPage "e79775" @default.
• W2053662475 abstract "Introduction We have recently described an increased lymphocytic infiltration rate in breast carcinoma tissue is a significant response predictor for anthracycline/taxane-based neoadjuvant chemotherapy (NACT). The aim of this study was to prospectively validate the tumor-associated lymphocyte infiltrate as predictive marker for response to anthracycline/taxane-based NACT. Patients and Methods The immunological infiltrate was prospectively evaluated in a total of 313 core biopsies from HER2 negative patients of the multicenter PREDICT study, a substudy of the neoadjuvant GeparQuinto study. Intratumoral lymphocytes (iTuLy), stromal lymphocytes (strLy) as well as lymphocyte-predominant breast cancer (LPBC) were evaluated by histopathological assessment. Pathological complete response (pCR) rates were analyzed and compared between the defined subgroups using the exact test of Fisher. Results Patients with lymphocyte-predominant breast cancer (LPBC) had a significantly increased pCR rate of 36.6%, compared to non-LPBC patients (14.3%, p<0.001). LPBC and stromal lymphocytes were significantly independent predictors for pCR in multivariate analysis (LPBC: OR 2.7, p = 0.003, strLy: OR 1.2, p = 0.01). The amount of intratumoral lymphocytes was significantly predictive for pCR in univariate (OR 1.2, p = 0.01) but not in multivariate logistic regression analysis (OR 1.2, p = 0.11). Conclusion Confirming previous investigations of our group, we have prospectively validated in an independent cohort that an increased immunological infiltrate in breast tumor tissue is predictive for response to anthracycline/taxane-based NACT. Patients with LPBC and increased stromal lymphocyte infiltration have significantly increased pCR rates. The lymphocytic infiltrate is a promising additional parameter for histopathological evaluation of breast cancer core biopsies." @default.
• W2053662475 created "2016-06-24" @default.
• W2053662475 creator A5002071285 @default.
• W2053662475 creator A5003405177 @default.
• W2053662475 creator A5003665481 @default.
• W2053662475 creator A5007647646 @default.
• W2053662475 creator A5011410319 @default.
• W2053662475 creator A5018297283 @default.
• W2053662475 creator A5021367756 @default.
• W2053662475 creator A5024741688 @default.
• W2053662475 creator A5030427888 @default.
• W2053662475 creator A5033698551 @default.
• W2053662475 creator A5034420549 @default.
• W2053662475 creator A5042166924 @default.
• W2053662475 creator A5052454978 @default.
• W2053662475 creator A5052512508 @default.
• W2053662475 creator A5053845865 @default.
• W2053662475 creator A5057181684 @default.
• W2053662475 creator A5062227589 @default.
• W2053662475 creator A5068658647 @default.
• W2053662475 creator A5069413112 @default.
• W2053662475 creator A5078993145 @default.
• W2053662475 creator A5087559224 @default.
• W2053662475 date "2013-12-02" @default.
• W2053662475 modified "2023-10-13" @default.
• W2053662475 title "Prospective Validation of Immunological Infiltrate for Prediction of Response to Neoadjuvant Chemotherapy in HER2-Negative Breast Cancer – A Substudy of the Neoadjuvant GeparQuinto Trial" @default.
• W2053662475 cites W1498187417 @default.
• W2053662475 cites W1598843567 @default.
• W2053662475 cites W1600186066 @default.
• W2053662475 cites W1891141189 @default.
• W2053662475 cites W1973091654 @default.
• W2053662475 cites W1973855239 @default.
• W2053662475 cites W1979379635 @default.
• W2053662475 cites W2001498331 @default.
• W2053662475 cites W2001646586 @default.
• W2053662475 cites W2010671504 @default.
• W2053662475 cites W2019182330 @default.
• W2053662475 cites W2023980114 @default.
• W2053662475 cites W2031576122 @default.
• W2053662475 cites W2044253211 @default.
• W2053662475 cites W2046972425 @default.
• W2053662475 cites W2053122486 @default.
• W2053662475 cites W2053934419 @default.
• W2053662475 cites W2069372863 @default.
• W2053662475 cites W2087179076 @default.
• W2053662475 cites W2088160256 @default.
• W2053662475 cites W2096151993 @default.
• W2053662475 cites W2101654319 @default.
• W2053662475 cites W2103724008 @default.
• W2053662475 cites W2105459360 @default.
• W2053662475 cites W2107894271 @default.
• W2053662475 cites W2113242459 @default.
• W2053662475 cites W2114043422 @default.
• W2053662475 cites W2116576993 @default.
• W2053662475 cites W2120338564 @default.
• W2053662475 cites W2125396123 @default.
• W2053662475 cites W2125789181 @default.
• W2053662475 cites W2127267391 @default.
• W2053662475 cites W2132516902 @default.
• W2053662475 cites W2137074525 @default.
• W2053662475 cites W2138600064 @default.
• W2053662475 cites W2138734774 @default.
• W2053662475 cites W2139510434 @default.
• W2053662475 cites W2140633375 @default.
• W2053662475 cites W2140654333 @default.
• W2053662475 cites W2146146786 @default.
• W2053662475 cites W2150633526 @default.
• W2053662475 cites W2157058802 @default.
• W2053662475 cites W2160117150 @default.
• W2053662475 cites W2162929947 @default.
• W2053662475 cites W2164540420 @default.
• W2053662475 cites W2171481006 @default.
• W2053662475 doi "https://doi.org/10.1371/journal.pone.0079775" @default.
• W2053662475 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3846472" @default.
• W2053662475 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24312450" @default.
• W2053662475 hasPublicationYear "2013" @default.
• W2053662475 type Work @default.
• W2053662475 sameAs 2053662475 @default.
• W2053662475 citedByCount "184" @default.
• W2053662475 countsByYear W20536624752014 @default.
• W2053662475 countsByYear W20536624752015 @default.
• W2053662475 countsByYear W20536624752016 @default.
• W2053662475 countsByYear W20536624752017 @default.
• W2053662475 countsByYear W20536624752018 @default.
• W2053662475 countsByYear W20536624752019 @default.
• W2053662475 countsByYear W20536624752020 @default.
• W2053662475 countsByYear W20536624752021 @default.
• W2053662475 countsByYear W20536624752022 @default.
• W2053662475 countsByYear W20536624752023 @default.
• W2053662475 crossrefType "journal-article" @default.
• W2053662475 hasAuthorship W2053662475A5002071285 @default.
• W2053662475 hasAuthorship W2053662475A5003405177 @default.
• W2053662475 hasAuthorship W2053662475A5003665481 @default.
• W2053662475 hasAuthorship W2053662475A5007647646 @default.
• W2053662475 hasAuthorship W2053662475A5011410319 @default.
• W2053662475 hasAuthorship W2053662475A5018297283 @default.
• W2053662475 hasAuthorship W2053662475A5021367756 @default.
• W2053662475 hasAuthorship W2053662475A5024741688 @default.

• next